Cuba develops new arthritis drug in face of U.S. embargo
14:55, February 16, 2011
Cuban scientists have developed a new arthritis drug to replace a similar imported drug blocked by the U.S. economic sanctions, a health official said on Tuesday.
The new radiopharmaceutical medicine developed by the Isotopes Center of the Ministry of Science, Technology and Environment is named "P32 chromic phosphate."
Enrique Garcia Rodriguez, chief of Nuclear Medicine of the General Hospital "Enrique Cabrera" in Havana, P32 phosphate is similar to the U.S. product "Fosfocol."
The therapy involves injecting the drug into the joints with chronic synovial inflammation to reduce the pain and improve the joints' function.
More:
http://english.people.com.cn/90001/90777/90852/7289884.html